AMN Healthcare Services, Inc.
$20.46
▼
-1.94%
2026-04-21 05:16:01
www.amnhealthcare.com
NYQ: AMN
Explore AMN Healthcare Services, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$790.91 M
Current Price
$20.46
52W High / Low
$23.74 / $14.87
Stock P/E
—
Book Value
$16.7
Dividend Yield
—
ROCE
2.19%
ROE
-14.19%
Face Value
—
EPS
$-2.48
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
2,664
Beta
0.25
Debt / Equity
125.09
Current Ratio
0.94
Quick Ratio
0.94
Forward P/E
15.72
Price / Sales
0.25
Enterprise Value
$1.46 B
EV / EBITDA
7.69
EV / Revenue
0.54
Rating
Hold
Target Price
$22.21
EPS Forecast (FY)
—
Pros
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Aveanna Healthcare Holdings Inc. | $6.87 | 6.54 | $1.47 B | — | 16.39% | 6.16% | $10.32 / $3.73 | $0.93 |
| 2. | Cross Country Healthcare, Inc. | $9.96 | — | $317.69 M | — | -1.05% | -25.57% | $14.99 / $7.43 | $10.18 |
| 3. | Encompass Health Corporation | $103.27 | 18.68 | $10.28 B | 0.72% | 16.84% | 24.82% | $127.99 / $92.77 | $24.38 |
| 4. | biote Corp. | $2.24 | 3.25 | $87.8 M | — | 56.77% | -32.89% | $4.75 / $1.27 | $-1.91 |
| 5. | Strata Critical Medical, Inc. | $4.52 | 9.61 | $397.54 M | — | -7.31% | -8.01% | $6.02 / $2.51 | $4.18 |
| 6. | Auna SA | $5.52 | 14.63 | $415.95 M | — | 14.53% | 6.54% | $7.39 / $4.46 | $6.11 |
| 7. | Cryo-Cell International, Inc. | $3.56 | — | $27.71 M | 11.63% | 11.54% | 15.27% | $6.35 / $2.72 | $-2.31 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 748.23 M | 634.5 M | 658.17 M | 689.53 M | 734.71 M | — |
| Operating Profit | 8.16 M | 8.44 M | 4.06 M | 12.51 M | 19.91 M | — |
| Net Profit | -7.7 M | 29.29 M | -116.2 M | -1.09 M | -187.53 M | — |
| EPS in Rs | -0.2 | 0.76 | -3.01 | -0.03 | -4.85 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 2.73 B | 2.98 B | 3.79 B | 5.24 B |
| Operating Profit | 33.17 M | 119.78 M | 346.23 M | 647.1 M |
| Net Profit | -95.7 M | -146.98 M | 210.68 M | 444.05 M |
| EPS in Rs | -2.48 | -3.8 | 5.45 | 11.49 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 2.09 B | 2.42 B | 2.92 B | 2.89 B |
| Total Liabilities | 1.45 B | 1.71 B | 2.09 B | 1.84 B |
| Equity | 642.11 M | 706.62 M | 831.26 M | 1.04 B |
| Current Assets | 545.38 M | 594.91 M | 841.68 M | 1.09 B |
| Current Liabilities | 577.61 M | 545.78 M | 656.12 M | 857.93 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 269.46 M | 320.42 M | 372.17 M | 653.73 M |
| Investing CF | 4.3 M | -79.94 M | -412.49 M | -170.71 M |
| Financing CF | -295.89 M | -259.45 M | 10.73 M | -591.87 M |
| Free CF | 233.83 M | 239.53 M | 266.78 M | 572.81 M |
| Capex | -35.63 M | -80.89 M | -105.39 M | -80.92 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | -8.49% | -21.26% | -27.73% | — |
| Earnings Growth % | 34.89% | -169.76% | -52.56% | — |
| Profit Margin % | -3.51% | -4.93% | 5.56% | 8.47% |
| Operating Margin % | 1.21% | 4.01% | 9.14% | 12.34% |
| Gross Margin % | 28.35% | 30.81% | 32.98% | 32.74% |
| EBITDA Margin % | 3.7% | 2.38% | 13.18% | 14.96% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.